Results 161 to 170 of about 14,994 (217)

Adherence to sulfadoxine-pyrimethamine five-dose policy among pregnant women in an urban slum in Ghana: a mixed-methods study. [PDF]

Malar J
Iddrisu H, Tagoe EA, Bonful HA.
europepmc   +1 more source

Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo. [PDF]

Int J Parasitol Drugs Drug Resist
Djontu JC, Baina MT, Mbama Ntabi JD, Lissom A, Umuhoza DM, Assioro Doulamo NV, Vouvoungui CJ, Boumpoutou RK, Mouanga AM, Nguimbi E, Ntoumi F.   +10 more
europepmc   +1 more source

Systematic Review and Geospatial Modeling of Molecular Markers of Resistance to Artemisinins and Sulfadoxine-Pyrimethamine in Plasmodium falciparum in India. [PDF]

Am J Trop Med Hyg
Nain M, Dhorda M, Flegg JA, Gupta A, Harrison LE, Singh-Phulgenda S, Otienoburu SD, Harriss E, Bharti PK, Behera B, Rahi M, Guerin PJ, Sharma A.   +12 more
europepmc   +1 more source

Effect of Antenatal Monthly Sulfadoxine-Pyrimethamine, Alone or with Azithromycin, on Gestational Weight Gain and Anemia during Pregnancy and One Month Postpartum in Malawi: A Randomized Controlled Trial Secondary Analysis. [PDF]

Am J Trop Med Hyg
Luntamo M, Hallamaa L, Kulmala T, Maleta K, Ashorn P.   +4 more
europepmc   +1 more source

Understanding potential non-malarial benefits of sulfadoxine-pyrimethamine treatment during pregnancy on birthweight: a scoping review

Sen S, Salazar PMd, Moehrle JJ, Penny MA.   +3 more
europepmc   +1 more source

Effect of knowledge of sulfadoxine-pyrimethamine (SP) as prophylaxis for malaria on its uptake for intermittent preventive treatment of malaria in pregnancy (IPTp): Application of inverse probability weighted regression adjustment (IPWRA) technique. [PDF]

PLoS One
Natuhamya C, Mwebesa E, Tumwesigye NM.
europepmc   +1 more source

Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.

Lancet Infect Dis
Idro R, Nkosi-Gondwe T, Opoka R, Ssenkusu JM, Dennis K, Tsirizani L, Akun P, Rujumba J, Nambatya W, Kamya C, Phiri N, Joanita K, Komata R, Innussa M, Tenywa E, John CC, Tarning J, Denti P, Wasmann RE, Ter Kuile FO, Robberstad B, Phiri KS.   +21 more
europepmc   +1 more source

Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine-pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey.

Lancet Microbe
Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, Bakari C, Madebe RA, Seth MD, Mandara CI, Popkin-Hall ZR, Moshi R, Mbwambo RB, Niaré K, MacInnis B, Francis F, Mbwambo D, Garimo I, Chacky F, Aaron S, Lusasi A, Molteni F, Njau RJA, Nhiga SL, Mohamed A, Bailey JA, Ishengoma DS.   +26 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

SUSCEPTIBILITY OF PLASMODIUM FALCIPARUM TO PYRIMETHAMINE AND SULFADOXINE/PYRIMETHAMINE IN KISUMU, KENYA

Lancet, The, 1982
Field studies were conducted in Kisumu, Kenya, to assess the susceptibility of local strains of Plasmodium falciparum to pyrimethamine alone (by a standard 7-day in-vivo test and a 48 h in-vitro field test) and to sulfadoxine-pyrimethamine (by a 7-day in-vivo test).
Phuc Nguyen-Dinh, H C Spencer, F C Churchill   +2 more
exaly   +3 more sources